File:Platelets in cancer EMT.jpg

Cancer cells undergo EMT to enter the bloodstream where they are able to recruit platelets to use as a physical barrier that helps protect the metastatic cancer cell from elimination by immune cells. The metastatic cancer cell can then use the attached platelets to adhere to P-selectin expressed by activated endothelial cells lining the blood vessel walls. After adhesion, the metastatic cancer cell exits the bloodstream at the secondary site to begin formation of a new tumor. Cs109809 (talk) 19:23, 29 November 2017 (UTC)

I, the copyright holder of this work, release this work into the public domain. This applies worldwide. In some countries this may not be legally possible; if so: I grant anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law.